Casey Hoffman1, Dena M Dunn2, Wanjiku F M Njoroge3. 1. Department of Child and Adolescent Psychiatry and Behavioral Sciences, Neonatal Follow-up Program, Newborn/Infant Intensive Care Unit, The Children's Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA, 19104, USA. 2. Department of Child and Adolescent Psychiatry and Behavioral Sciences, Neonatal Follow-up Program & Pediatric Feeding and Swallowing Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. 3. Department of Child and Adolescent Psychiatry and Behavioral Sciences, Young Child Clinic, Perelman School of Medicine at the University of Pennsylvania, 3440 Market Street, Suite 410, Philadelphia, PA, 19104, USA. njorogew@email.chop.edu.
Abstract
PURPOSE OF REVIEW: This review evaluates the state of the research regarding the effects of postpartum mental illness on the developing infant. It defines the scope of these disorders in the literature, and includes the impact of disorders referred to as perinatal mood and anxiety disorders (PMADs) on infants. RECENT FINDINGS: New research reveals that PMADs apply to not only mothers, but that fathers can also experience perinatal depression and anxiety. When untreated in a primary caregiver, PMADs adversely affect parental cognitions and beliefs, attachment to the infant, and the growing caregiver-infant relationship. PMADs affect early developmental outcomes of infants including neurosynaptic development, regulatory development, and developmental milestones. Early identification and treatment for PMADs are critical to ensure optimal infant development. Standardized and routine screening for PMADs, especially in the first 6 months postpartum, and cross-disciplinary communication among medical providers afford the best opportunity for early identification and treatment.
PURPOSE OF REVIEW: This review evaluates the state of the research regarding the effects of postpartum mental illness on the developing infant. It defines the scope of these disorders in the literature, and includes the impact of disorders referred to as perinatal mood and anxiety disorders (PMADs) on infants. RECENT FINDINGS: New research reveals that PMADs apply to not only mothers, but that fathers can also experience perinatal depression and anxiety. When untreated in a primary caregiver, PMADs adversely affect parental cognitions and beliefs, attachment to the infant, and the growing caregiver-infant relationship. PMADs affect early developmental outcomes of infants including neurosynaptic development, regulatory development, and developmental milestones. Early identification and treatment for PMADs are critical to ensure optimal infant development. Standardized and routine screening for PMADs, especially in the first 6 months postpartum, and cross-disciplinary communication among medical providers afford the best opportunity for early identification and treatment.
Authors: Katherine M Sharkey; Ijeoma N Iko; Jason T Machan; Johanna Thompson-Westra; Teri B Pearlstein Journal: Arch Womens Ment Health Date: 2015-08-01 Impact factor: 3.633
Authors: Rachel A Level; Shannon M Shisler; Danielle M Seay; Miglena Y Ivanova; Madison R Kelm; Rina D Eiden; Pamela Schuetze Journal: Depress Anxiety Date: 2021-08-26 Impact factor: 6.505
Authors: Snehal Murthy; Laurel Haeusslein; Stephen Bent; Elizabeth Fitelson; Linda S Franck; Christina Mangurian Journal: J Perinatol Date: 2021-03-10 Impact factor: 2.521
Authors: Matthew Bluett-Duncan; M Thomas Kishore; Divya M Patil; Veena A Satyanarayana; Helen Sharp Journal: PLoS One Date: 2021-06-25 Impact factor: 3.240